#Spain #Madrid #SteriLance #Onestep #SoftSense

SteriLance Launches Revolutionary Lancing Device in Spain

SteriLance Medical, a leader in personal blood sampling solutions, has officially launched its groundbreaking needle-free lancing device, the Onestep™, in Spain. This marks an important milestone as the company embarks on its European rollout, targeting a significant population of diabetes patients in the region. The Onestep lancing device, along with its companion SoftSense lancets, offers an unparalleled user experience in blood sampling, particularly for those who require frequent testing.

Innovative Features of Onestep

The Onestep lancing device is distinguished by its unique needle-free design, featuring a concealed needle until the very moment of use. This design, powered by SteriLance's patented Total Path Control™ (TPC) technology, ensures a virtually painless experience for users, significantly reducing the discomfort typically associated with blood sampling. The device operates using a straightforward four-step process: insert, twist, press, and eject the lancet.

• - Less Preparation: Compared to conventional lancing devices, Onestep halves the preparatory movements needed before taking a blood sample. This streamlined workflow can be a game-changer for users who struggle with anxiety or discomfort during blood tests.
• - Safety and Comfort: With the needle hidden during the entire process, users report feeling less anxious. In a recent study involving 30 participants, a remarkable 92% noted minimal to no pain during the procedure, while 87% expressed feeling safer because they did not have to see the needle.

Background on Diabetes in Spain

Spain has approximately 5.1 million adults living with diabetes, which represents one of the highest prevalence rates in Europe. Regular self-monitoring is essential for effective diabetes management, and devices like Onestep are designed to enhance adherence to daily monitoring routines. By minimizing pain and anxiety, SteriLance aims to help individuals manage their condition more effectively.

Availability and Future Rollout

The Onestep and SoftSense products are currently available at select pharmacies and partner e-commerce platforms across Spain. A larger distribution plan covering additional EU markets is set to roll out in the upcoming months, expanding the reach of SteriLance’s innovative products to more consumers in need.

SteriLance's commitment to quality and safety is evident, with both the Onestep and SoftSense being CE-MDR certified and compliant with ISO 13485 standards, designed specifically for frequent home capillary blood sampling.

For anyone interested in discovering more about Onestep and its features, additional information can be found on the official SteriLance website at SteriLance Innovations. Media inquiries or distribution questions can be directed to [email protected]

Conclusion
The launch of the Onestep device represents a significant step towards enhancing the quality of life for individuals managing diabetes in Spain and beyond. With its advanced needle-free technology and user-friendly design, SteriLance strives to make blood sampling a more accessible and comfortable experience for everyone.